written on 13.05.2014

Merck sells off eye drugs and Colorado manufacturing unit


Now the big pharma, headquartered in New Jersey, US, is selling off a number of ophthalmic products to Otsuka-based Santen Pharmaceuticals. The drugs being purchased by the Japanese pharma are all approved medicines for the treatment of glaucoma/ocular…